190 related articles for article (PubMed ID: 16298725)
1. Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration.
Rauhut AS; Dwoskin LP; Bardo MT
Nicotine Tob Res; 2005 Dec; 7(6):901-7. PubMed ID: 16298725
[TBL] [Abstract][Full Text] [Related]
2. Effect of bupropion on nicotine self-administration in rats.
Rauhut AS; Neugebauer N; Dwoskin LP; Bardo MT
Psychopharmacology (Berl); 2003 Aug; 169(1):1-9. PubMed ID: 12811464
[TBL] [Abstract][Full Text] [Related]
3. Rate-dependent effects of bupropion on nicotine self-administration and food-maintained responding in rats.
Stairs DJ; Dworkin SI
Pharmacol Biochem Behav; 2008 Oct; 90(4):701-11. PubMed ID: 18602678
[TBL] [Abstract][Full Text] [Related]
4. Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation.
Markou A; Paterson NE; Semenova S
Ann N Y Acad Sci; 2004 Oct; 1025():491-503. PubMed ID: 15542754
[TBL] [Abstract][Full Text] [Related]
5. Preexposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats.
Wilkinson JL; Palmatier MI; Bevins RA
Nicotine Tob Res; 2006 Feb; 8(1):141-6. PubMed ID: 16497608
[TBL] [Abstract][Full Text] [Related]
6. Investigating the actions of bupropion on dependence-related effects of nicotine in rats.
Shoaib M; Sidhpura N; Shafait S
Psychopharmacology (Berl); 2003 Feb; 165(4):405-12. PubMed ID: 12451438
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
[TBL] [Abstract][Full Text] [Related]
8. Nicotine and bupropion share a similar discriminative stimulus effect.
Young R; Glennon RA
Eur J Pharmacol; 2002 May; 443(1-3):113-8. PubMed ID: 12044800
[TBL] [Abstract][Full Text] [Related]
9. Bupropion hydrochloride produces conditioned hyperactivity in rats.
Wilkinson JL; Bevins RA
Physiol Behav; 2007 Apr; 90(5):790-6. PubMed ID: 17300819
[TBL] [Abstract][Full Text] [Related]
10. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.
Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ
J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
Sidhpura N; Redfern P; Rowley H; Heal D; Wonnacott S
Biochem Pharmacol; 2007 Oct; 74(8):1292-8. PubMed ID: 17678630
[TBL] [Abstract][Full Text] [Related]
12. Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats.
Franke RM; Park M; Belluzzi JD; Leslie FM
Eur J Neurosci; 2008 Jun; 27(11):2952-61. PubMed ID: 18588535
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
[TBL] [Abstract][Full Text] [Related]
14. Bupropion for the treatment of nicotine withdrawal and craving.
Mooney ME; Sofuoglu M
Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112
[TBL] [Abstract][Full Text] [Related]
15. Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules.
Green TA; Gehrke BJ; Bardo MT
Psychopharmacology (Berl); 2002 Aug; 162(4):373-8. PubMed ID: 12172690
[TBL] [Abstract][Full Text] [Related]
16. Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose.
Liu X; Caggiula AR; Palmatier MI; Donny EC; Sved AF
Psychopharmacology (Berl); 2008 Feb; 196(3):365-75. PubMed ID: 17932656
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
Sidhpura N; Redfern P; Wonnacott S
Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
[TBL] [Abstract][Full Text] [Related]
18. Reboxetine: attenuation of intravenous nicotine self-administration in rats.
Rauhut AS; Mullins SN; Dwoskin LP; Bardo MT
J Pharmacol Exp Ther; 2002 Nov; 303(2):664-72. PubMed ID: 12388649
[TBL] [Abstract][Full Text] [Related]
19. Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion.
Semba J; Wakuta M
Psychiatry Clin Neurosci; 2008 Aug; 62(4):435-41. PubMed ID: 18778441
[TBL] [Abstract][Full Text] [Related]
20. Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.
Biala G; Kruk M
J Pharm Pharmacol; 2009 Apr; 61(4):493-502. PubMed ID: 19298697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
